Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- CheckyesterdayChange DetectedVersion history shows the record revised from v3.5.3 to v3.5.4. This indicates a minor update to the page's revision metadata on ClinicalTrials.gov, not affecting the displayed content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s displayed revision number was updated from v3.5.2 to v3.5.3, indicating a minor update to the site/app version shown in the footer. No changes to the trial record history entries themselves are indicated by this revision label update.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRecord History was updated to add revision v3.5.0 and remove revision v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the record history.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page history now includes Revision: v3.4.2; prior notices about funding lapse and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.